# K172014: Wedge Microcatheter

- Pathway: 510(k) (Traditional)
- Applicant: MicroVention, Inc.
- Decided: Apr 5, 2018 after 276 days
- Product code: DQY (Catheter, Percutaneous)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K960806 (1996). 7 ancestors in all.
3 later devices descend from it; 2 cite it directly.
0 of 11 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K093160: Headway 21 Microcatheter, Model: MC212150S, MicroVention, Inc. (2009) Summary page 4.
- K083343: Headway 17 Microcatheter, MicroVention, Inc. (2008) Summary page 4.
- K163259: AXS Offset Delivery Assist Catheter, Stryker Neurovascular (2017). Cleared while this submission was under review Summary page 4.

## Most influential descendants
- K230609: NG Delivery Catheter (2023), 1 descendant of its own
- K252569: Carrier XL Delivery Catheter (2025), 0 descendants of its own
- K232542: Wedge XL Delivery Catheter (2024), 0 descendants of its own

## Indications for use
The Wedge Microcatheter is intended for general intravascular use, including the peripheral, coronary and neuro vasculature for the infusion of diagnostic agents, such as contrast media, and to assist in the delivery of interventional devices, such as the SOFIA 6F Catheter, in the neurovasculature.

Source page: https://510kreport.com/device/K172014
Methodology: https://510kreport.com/methodology